Citations

Clear

25 citation(s) found for "Kumar, Arun".

Trends and Outcomes of Acute Liver Failure in Patients with COVID-19 Infection: Insights from United States National Inpatient Sample Analysis 2020–2022
Arumairaj, Antony , Dhanani, Dili , Veluswamy, Anuradha Shunmugam , Kumar, Abhishek Kumar Mariswamy Arun , Moscoso, José Andrés Pérez, Mittal, Jayesh , Prajapati, Vipulkumar, Korpu, Divya , Dhorajiya, Poojaben

Mayo Clinic

Livers | July 16, 2026 | Volume: 6 | Issue: 4 | Pages: 70

10.3390/livers6040070 Get It

Introduction: COVID-19, in addition to its direct detrimental respiratory infection, is associated with multiple systemic complications involving different organs, including the liver. COVID-19 has been associated with liver injury through multiple mechanisms, including direct viral effects on liver cells, immune-mediated injury, cytokine-driven inflammation, ischemic hepatitis, microvascular thrombosis, and sepsis-related multiorgan dysfunction. Acute liver failure (ALF) is the acute form of liver damage, which has a high mortality, and recovery is dependent on various factors. We studied the effect of COVID-19 on clinical outcomes such as mortality, length of stay, and need for non-invasive and invasive ventilation in patients with acute liver failure. Methods: We performed a retrospective cohort analysis using the Nationwide Inpatient Sample (NIS) database from 2020 to 2022. Adult patients admitted to the hospital with acute liver failure were divided into 2 groups based on their COVID-19 infection status. We analyzed differences in mortality, length of stay, need for non-invasive and invasive ventilation, acute kidney injury, need for renal replacement therapy, and total charges to evaluate the effects on outcomes, and the results were then adjusted for demographic and hospital factors. Results: Of 633,155 patients with acute liver failure, 66,785 had concurrent COVID-19 infection, while 566,370 did not. Patients with concurrent COVID-19 infection had significantly higher in-hospital mortality (63.9% vs. 36.0%) and greater utilization of noninvasive ventilation (14.9% vs. 6.4%), invasive mechanical ventilation (68.9% vs. 41.7%), higher incidence of acute kidney injury (81.4% vs. 70.3%) and higher need for renal replacement therapy (26.8% vs. 16.9%). They also experienced longer hospital stays (17.1 vs. 10.7 days) and higher total charges ($345,072 vs. $221,268). The findings were statistically significant after adjusting for demographics and clinical factors. Conclusions: Patients hospitalized with acute liver failure and concurrent COVID-19 infection experienced worse clinical outcomes, including higher in-hospital mortality, greater need for ventilatory support and renal replacement therapy, and higher hospital resource utilization. Notably, COVID-19 was independently associated with worse outcomes even among patients with fewer baseline comorbidities. These findings underscore the importance of early recognition of COVID-19 in patients presenting with acute liver failure, as well as prompt, multidisciplinary management to optimize clinical outcomes.
Targeting the JAK-STAT pathway: Successful use of abrocitinib in refractory prurigo nodularis
De, Abhishek, Chakraborty, Disha, Ahmed, S. K. Shahriar, De, Abhishek , Singh, Arun Kumar , Chakraborty, Disha , Ahmed, S. K. Shahriar

Mayo Clinic

Indian Journal of Skin Allergy | March 20, 2026 | Volume: 5 | Issue: No issue available | Pages: 105-106

10.25259/ijsa_83_2025 Get It

Targeted plasma proteomics uncover novel proteins associated with KIF5A -linked SPG10 and ALS spectrum disorders
Orlacchio, Antonio , Munain, Adolfo López de, Vucic, Steve , Barakat, Tahsin Stefan , Petrucelli, Leonard , Prudencio, Mercedes , Weishaupt, Jochen H., Prudencio, Mercedes , Dulski, Jarosław , Boddapati, Arun Kumar , Risi, Barbara , Iruzubieta, Pablo , Fernández‐Torrón, Roberto , Castillo‐Triviño, Tamara , Munain, Adolfo López de, Padovani, Alessandro , Kaat, Laura Donker , Landers, John E. , Weishaupt, Jochen H. , Prokop, Andreas , Filosto, Massimiliano , Wszołek, Zbigniew K. , Pant, Devesh C.

Mayo Clinic

No container title available | May 2, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.04.29.651203 Get It

Abstract KIF5A (Kinesin family member 5A) is a motor protein that functions as a key component of the axonal transport machinery. Variants in KIF5A are linked to several neurodegenerative diseases, mainly spastic paraplegia type 10 (SPG10), Charcot-Marie-Tooth disease type 2 (CMT2), and amyotrophic lateral sclerosis (ALS). These diseases share motor neuron involvement but vary significantly in clinical presentation, severity, and progression. KIF5A variants are mainly categorized into N-terminal variants associated with SPG10/CMT2 and C-terminal variants linked to ALS. This study utilized a novel multiplex NULISA targeted platform to analyze plasma proteome from KIF5A -linked SPG10, ALS patients and compared to healthy controls. Our results revealed distinct proteomic signatures, with significant alterations in proteins related to synaptic function, and inflammation. Notably, neurofilament light polypeptide, a biomarker for neurodegenerative diseases, was elevated in KIF5A ALS but not in SPG10 patients. Moreover, these findings can now be taken forward to gain mechanistic understanding of axonopathies linking to N- vs C-terminal KIF5A variants affecting both central and peripheral nervous systems.
Spatially-Delineated Domain-Adapted AI Classification: An Application for Oncology Data
Farhadloo, Majid , Leontovich, Alexey A. , Shekhar, Shashi , Sharma, Arun , Sharma, Arun Kumar , Markovic, Svetomir N. , Shekhar, Shashi

Mayo Clinic

Proceedings of the 2025 SIAM International Conference on Data Mining (SDM) | April 30, 2025 | Volume: No volume available | Issue: No issue available | Pages: 487-496

10.1137/1.9781611978520.53 Get It

Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States
Sisk, Bryan A. , Eng, Whitney , Mack, Joana M. , Tran, Andrew , Ogino, Jayme , Pearson, Erika , Bies, Joshua J., Smink, Gayle , Shah, Sonal D. , Mohney, Lindsey , Fassel, Hannah, Schulte, Rachael , Tessem, Renae A., Swaminathan, Neeraja , McLean, Thomas W. , Alturky, Sara , Wu, Melinda , Atkinson, Autumn, Al‐Huniti, Ahmad , Massey, Gita , Engel, Elissa , Echols, Tyson C. , Kumar, Sumukh Arun , Fox, Michael D. , King, Katherine A., Mack, Joana , Pearson, Erika , Shah, Sonal D , Swaminathan, Neeraja , McLean, Thomas W , Blatt, Julie , Massey, Gita , Ricci, Kiersten , Echols, Tyson , Fox, Michael , Sisk, Bryan A , Aye, Jamie M. , Chang, Vivian Y. , Hogeling, Marcia , Atkinson, Autumn

Mayo Clinic

Pediatric Blood & Cancer | March 17, 2025 | Volume: 72 | Issue: 6 | Pages: No page available

10.1002/pbc.31661 | PMID 40091541 Get It

ABSTRACTPatients with vascular anomalies (VAs) require expert multidisciplinary care. No prior studies have characterized the sociodemographic characteristics across multiple VA centers. We collected data on 5783 patients receiving care at 20 VA centers between July 1, 2020 through December 31, 2022. Male patients were underrepresented compared to the state‐level census data at 17/20 centers. Black and Asian patients were underrepresented at 14/20 and 12/20 centers, respectively. The median distance to the hospital was 48 miles, and median age was 12.0 years. These data suggest that race, sex, age, and distance from the hospital could impede the ability to access expert VA care.
Abstract 19131: Stent-Based Vascular Cell Delivery for Therapeutic VEGF-Induced Angiogenesis
Doyle, Brendan, Martin, Kenneth, Ali, Mohammed T. , Skelding, Kimberley A, Gleeson, Birgitta , Ritman, Erik L., Caplice, Noel M. , Kumar, Arun , Skelding, Kimberley, Wang, Shaohua , Russell, Stephen J

Mayo Clinic

Circulation | April 23, 2024 | Volume: 128 | Issue: suppl_22 | Pages: No page available

10.1161/circ.128.suppl_22.a19131 Get It

Site specific targeting remains an elusive goal for stem cell and gene therapies in the cardiovascular field. One promising option involves use of modified 3D stent designs that deliver larger cell/gene payloads to specific disease sites using the versatility of percutaneous vascular access. Here, we engineered smooth muscle cells (SMCs) placed in a 3D metallic stent scaffold to deliver high local concentrations of an angiogenic gene (VEGF165) in a porcine model of chronic total occlusion involving ameroid placement on the proximal left circumflex (LCx) artery(n≥8 per group). Engineered SMCs were retained within the mesh stent structure (479 ± 47.4 SMC/mm2) and were competent for VEGF production in vitro (8.8 ± 1.8 ng/ml in media). Following implantation, micro CT analyses revealed that stents loaded with VEGF producing SMCs significantly enhanced vasa vasora microvessel density (5.43 ± 0.46 vs 2.14 ± 0.19 vessels/mm2, p<0.001) with a concomitant increase in tissue VEGF protein levels (277.9 ± 85.7 vs 18.8 ± 4.4 pg/mg protein, p<0.0001). Formation of endothelial cell colonies from peripheral blood mononuclear cells was significantly increased with the implantation of VEGF-secreting cells suggesting increased angiogenic potential (7.0 ± 2.0 versus 41.6 ± 4.5, EC:CFU p<0.0001). VEGF secreting mesh stent placement enhanced regional blood flow analyses determined by microsphere analyses as well as improving regional wall motion in the LCx-related territory (p<0.05) as well as left ventricular function assessed in terms of ejection fraction (34.2 ± 6.7% vs 61.2 ± 5.2% P<0.001) and dp/dt (p<0.001) Our data indicate robust clinically relevant angiogenesis can be achieved in a human scale porcine chronic vascular occlusion model following stent based delivery of angiogenic cells. This may have implications for percutaneous delivery of stem cells, genes and secreted therapeutic factors in cardiovascular disease in general and in creation of percutaneous microvascular bypass networks in the setting of chronic vaso-occlusive disease in particular.
Towards Spatially-Lucid AI Classification in Non-Euclidean Space: An Application for MxIF Oncology Data
Farhadloo, Majid , Gupta, Jayant, Leontovich, Alexey A. , Sharma, Arun , Sharma, Arun Kumar , Markovic, Svetomir N. , Shekhar, Shashi

Mayo Clinic

Proceedings of the 2024 SIAM International Conference on Data Mining (SDM) | April 11, 2024 | Volume: No volume available | Issue: No issue available | Pages: 616-624

10.1137/1.9781611978032.71 Get It

Ensemble Deep Learning Derived from Transfer Learning for Classification of COVID-19 Patients on Hybrid Deep-Learning-Based Lung Segmentation: A Data Augmentation and Balancing Framework
Dubey, Arun Kumar , Chabert, Gian Luca , Carriero, Alessandro , Paschè, Alessio , Agarwal, Sushant , Mohanty, Lopamudra , Nillmani, Sharma, Neeraj , Jain, Achin , Kumar, Ashish , Sobel, David , Laird, John R. , Singh, Inder M. , Singh, Narpinder , Tsoulfas, George, Fouda, Mostafa M. , Višković, Klaudija , Kukuljan, Melita , Al-Maini, Mustafa , El‐Baz, Ayman , Saba, Luca , Agarwal, Sushant , Nillmani , Sobel, David W , Tsoulfas, George , Fouda, Mostafa M , Alizad, Azra , Viskovic, Klaudija , Kukuljan, Melita , El-Baz, Ayman , Danna, Pietro , Yadav, Sarita , Kalra, Mannudeep K. , Alizad, Azra , Kitas, George D. , Khanna, Narendra N. , Suri, Jasjit S.

Mayo Clinic

Diagnostics | June 5, 2023 | Volume: 13 | Issue: 11 | Pages: 1954

10.3390/diagnostics13111954 | PMID 37296806 Get It

Background and motivation: Lung computed tomography (CT) techniques are high-resolution and are well adopted in the intensive care unit (ICU) for COVID-19 disease control classification. Most artificial intelligence (AI) systems do not undergo generalization and are typically overfitted. Such trained AI systems are not practical for clinical settings and therefore do not give accurate results when executed on unseen data sets. We hypothesize that ensemble deep learning (EDL) is superior to deep transfer learning (TL) in both non-augmented and augmented frameworks. Methodology: The system consists of a cascade of quality control, ResNet–UNet-based hybrid deep learning for lung segmentation, and seven models using TL-based classification followed by five types of EDL’s. To prove our hypothesis, five different kinds of data combinations (DC) were designed using a combination of two multicenter cohorts—Croatia (80 COVID) and Italy (72 COVID and 30 controls)—leading to 12,000 CT slices. As part of generalization, the system was tested on unseen data and statistically tested for reliability/stability. Results: Using the K5 (80:20) cross-validation protocol on the balanced and augmented dataset, the five DC datasets improved TL mean accuracy by 3.32%, 6.56%, 12.96%, 47.1%, and 2.78%, respectively. The five EDL systems showed improvements in accuracy of 2.12%, 5.78%, 6.72%, 32.05%, and 2.40%, thus validating our hypothesis. All statistical tests proved positive for reliability and stability. Conclusion: EDL showed superior performance to TL systems for both (a) unbalanced and unaugmented and (b) balanced and augmented datasets for both (i) seen and (ii) unseen paradigms, validating both our hypotheses.
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study
Ziadé, Nelly , Aoude, Marc, Hmamouchi, Ihsane , Naveen, R, Sen, Parikshit , Joshi, Mrudula , Agarwal, Vishwesh , Kardeş, Sinan , Day, Jessica , Milchert, Marcin , Gheita, Tamer A. , Salim, Babur , Velikova, Tsvetelina , Parodis, Ioannis , Nikiphorou, Elena , Tan, Ai Lyn , Kuwana, Masataka , Chinoy, Hector , Agarwal, Vikas , Gupta, Latika, Group, the COVAD Study, Singh, Yogesh Preet , Pandya, Sapan C , Sharma, Aman , Manoj, Manesh , Patro, Pradeepta Sekhar , Ajmani, Sajal, Chowdhury, Abhra Chandra , Shenoy, Padnamabha, Asranna, Ajay, Bommakanti, Keerthi Talari, Shukla, Anuj , Pandey, Arun Kumar R, Pauling, John D , Sambataro, Gianluca , Atzeni, Fabiola , Parisi, Simone , Bocci, Elena Bartoloni, Sainaghi, Pier Paolo , Orsolini, Giovanni , Angelis, Rossella De , Danielli, Maria Giovanna, Tehozol, Erick Adrian Zamora , Loarce‐Martos, Jesus , Prieto‐González, Sergio , González, Raquel , Nakashima, Ran , Sato, Shinji , Kimura, Naoki , Kaneko, Yuko , Tomaras, Stylianos , Aharonov, Or, Maurier, F. , Meyer, Alain, Nagy‐Vincze, Melinda , Limaye, Vidya , Hudson, Marie , Landon‐Cardinal, Océane , Shaharir, Syahrul Sazliyana , Zuleta, Wilmer Gerardo Rojas, Silva, José António Pereira, Ravichandran, Naveen , Gupta, Latika , Agarwal, Vikas , Naveen, R , Lilleker, James B , Sen, Parikshit , Joshi, Mrudula , Agarwal, Vishwesh , Kardes, Sinan , Day, Jessica , Makol, Ashima , Milchert, Marcin , Gheita, Tamer , Salim, Babur , Velikova, Tsvetelina , Gracia-Ramos, Abraham Edgar , Parodis, Ioannis , Nikiphorou, Elena , Chatterjee, Tulika , Tan, Ai Lyn , Saavedra, Miguel A , Shinjo, Samuel Katsuyuki , Knitza, Johannes , Kuwana, Masataka , Nune, Arvind , Cavagna, Lorenzo , Distler, Oliver , Chinoy, Hector , Agarwal, Vikas , Aggarwal, Rohit , Gupta, Latika , Ziade, Nelly , Pauling, John D , Zamora Tehozol, Erick Adrian , De Angelis, Rossella , Singh, Yogesh Preet , Makol, Ashima , Gracia‐Ramos, Abraham Edgar , Chatterjee, Tulika , Shinjo, Samuel Katsuyuki , Nune, Arvind , Distler, Oliver , Aggarwal, Rohit , Group, the COVAD Study, Barman, Bhupen , Ranjan, Rajiv , Jain, Avinash , Pilania, Rakesh Kumar , Gupta, Vikas , Kavadichanda, Chengappa G. , Ajmani, Sajal , Phatak, Sanat B. , Goswami, Rudra P , Mathew, Ashish Jacob , Chandwar, Kunal , Cansu, Döndü Üsküdar , Wincup, Chris , Papa, Nicoletta Del , Govoni, Marcello , Bocci, Elena Bartoloni, Sebastiani, Gian Domenico , Fusaro, Enrico , Sebastiani, Marco , Quartuccio, Luca , Franceschini, Franco , Venerito, Vincenzo , Traboco, Lisa S , Wibowo, Suryo Anggoro Kusumo , Rojas Serrano, Jorge , Torre, Ignacio García‐De La , Gonzalez, Raquel Aranega, Yoshida, Akira , Gromova, Margarita Aleksandrovna , Hoff, Leonardo Santos , Giannini, Margherita , Campagne, Julien , Meyer, Alain , Langguth, Daman , Needham, Merrilee , Srivastav, Nilesh , Silva, José António Pereira, Fonseca, João Eurico , Zimba, Olena

Mayo Clinic

Rheumatology | May 25, 2023 | Volume: 63 | Issue: 3 | Pages: 657-664

10.1093/rheumatology/kead250 | PMID 37228012 Get It

Abstract Objectives We aimed to explore current practice and interregional differences in the treatment of idiopathic inflammatory myopathies (IIMs). We triangulated these observations considering countries' gross national income (GNI), disease subtypes, and symptoms using patient-reported information. Methods A cross-sectional ancillary analysis of the ‘COVID-19 vaccination in auto-immune disease’ (COVAD) e-survey containing demographic characteristics, IIM subtypes (DM, PM, IBM, anti-synthetase syndrome [ASSD], immune-mediated necrotizing myopathy [IMNM], overlap myopathies [OM]), current symptoms (surrogate for organ involvement) and treatments (corticosteroids [CS], immunomodulators [IM], i.e. antimalarials, immunosuppressants [IS], IVIG, biologic treatments and targeted-synthetic small molecules). Treatments were presented descriptively according to continents, GNI, IIM and organ involvement, and associated factors were analysed using multivariable binary logistic regressions. Results Of 18 851 respondents from 94 countries, 1418 with IIM were analysed (age 61 years, 62.5% females). DM (32.4%), IBM (24.5%) and OM (15.8%) were the most common subtypes. Treatment categories included IS (49.4%), CS (38.5%), IM (13.8%) and IVIG (9.4%). Notably, treatments varied across regions, GNI categories (IS mostly used in higher-middle income, IM in lower-middle income, IVIG and biologics largely limited to high-income countries), IIM subtypes (IS and CS associated with ASSD, IM with OM and DM, IVIG with IMNM, and biologic treatments with OM and ASSD) and disease manifestations (IS and CS with dyspnoea). Most inter-regional treatment disparities persisted after multivariable analysis. Conclusion We identified marked regional treatment disparities in a global cohort of IIM. These observations highlight the need for international consensus-driven management guidelines considering patient-centred care and available resources.
Safety and Efficacy of Endoscopic Full Thickness Resection of Upper Gastrointestinal Lesions Using a Full Thickness Resection Device
Bomman, Shivanand , Klair, Jagpal S. , Muthusamy, Arun Kumar, Nagra, Navroop , Chandra, Shruti , Shanmugam, Meena, Perisetti, Abhilash , Aggarwal, Avin , Gavini, Hemanth K., Krishnamoorthi, Rajesh , Canakis, Andrew

Mayo Clinic

Journal of Clinical Gastroenterology | February 2, 2023 | Volume: 58 | Issue: 1 | Pages: 46-52

10.1097/mcg.0000000000001803 | PMID 36730483 Get It

Introduction: Endoscopic full-thickness resection (EFTR) is a promising technique that allows for a minimally invasive resection of mucosal and submucosal lesions in the gastrointestinal (GI) tract. The data regarding the efficacy and safety of performing EFTR of upper GI lesions using a full-thickness resection device (FTRD) is limited. Hence, we performed a systematic review and meta-analysis of the studies that evaluated this technique. Methods: We performed a comprehensive systematic search of multiple electronic databases and conference proceedings that reported outcomes of EFTR using the FTRD system. The weighted pooled rates of technical success, complete (R0) resection, adverse events (AE), and residual or recurrent lesions were analyzed with 95% CI using the random effects model. Results: Eight studies with a total of 139 patients who underwent EFTR of upper GI lesions were included in the study. The pooled, weighted rate of technical success was 88.2% (95% CI: 81.4-92.7%, I 2 : 0). The R0 resection rate was 70.7% (95% CI: 62.5-77.8%, I 2 : 0). Overall AE rates were 22.1% (95% CI: 15.8-30.1%, I 2 : 0), however, most of the AEs were minor. Of the patients who had follow-up endoscopies, the residual and/or recurrent lesion rate was 6.1% (95% CI: 2.4-14.4%, I 2 : 0). Heterogeneity in the analysis was low. Conclusions: EFTR using the FTRD seems to be effective and safe with acceptable R0 resection rates and low recurrence rates. Further prospective studies are required to validate our results and to compare various modalities of endoscopic resection with this single-step EFTR device.